Cited by 22Bipolar Disorder and TreatmentSchizophrenia research and treatmentPersonality Disorders and Psychopathology

Impact of irritability: a 2‐year observational study of outpatients with bipolar I or schizoaffective disorder

Open access
Berk, Lesley, Hallam, Karen T, Venugopal, Kamalesh, Lewis, Andrew James, Austin, David W, Kulkarni, Jayashri, Dodd, Seetal, de Castella, Anthony +2 more·2017·Bipolar Disorders

Abstract

Objectives: Many people experience irritability when manic, hypomanic, or depressed, yet its impact on illness severity and quality of life in bipolar and schizoaffective disorders is poorly understood. This study aimed to examine the relationship between irritability and symptom burden, functioning, quality of life, social support, suicidality, and overall illness severity in a naturalistic cohort of people with bipolar I or schizoaffective disorder. Methods: We used data from 239 adult outpatients with bipolar I or schizoaffective disorder in the Bipolar Comprehensive Outcomes Study (BCOS) – a non‐interventional observational study with a 2‐year follow‐up period. Baseline demographic and clinical characteristics of participants with and without irritability were compared. A mixed‐model repeated measures analysis was conducted to examine the longitudinal effect of irritability on clinical and quality‐of‐life variables over follow‐up using significant baseline variables. Results: At baseline, 54% of participants were irritable. Baseline irritability was associated with illness severity, mania, depression, psychotic symptoms, suicidality, poor functioning, and quality of life, but not diagnosis (schizoaffective/bipolar disorder). Participants with irritability were less likely to have a partner and perceived less adequate social support. On average, over follow‐up, those with irritability reported more symptoms, functional impairment, and suicidality. Furthermore, the effects of irritability could not be fully explained by illness severity. Conclusions: Irritability was associated with more negative symptomatic, functional, and quality‐of‐life outcomes and suicidality. The identification, monitoring, and targeted treatment of irritability may be worth considering, to enhance health and wellbeing outcomes for adults with bipolar and schizoaffective disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bdi.12486

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There remains controversy around the inclusion of irritability, which is a far more non-specific phenomenon with much overlap with disorders such as ADHD, conduct disorder, and personality disorders.

    “There remains controversy around the inclusion of irritability, which is a far more non-specific phenomenon with much overlap with disorders such as ADHD, conduct disorder, and personality disorders [38].”

    From Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies (2020) · cites this paper as [38]

    The Introduction describes irritability as transdiagnostic and non-specific. The Comorbidity section says personality disorders may involve irritability and discusses conduct problems, but it does not establish overlap with ADHD or specifically describe controversy over irritability’s inclusion. Page numbers are unavailable in our copy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

1 of the 109 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. I. Conceptual framework and item selection. Medical care. 1992; 30:473-83.
  2. Berk, L., Hallam, K. T., Venugopal, K., Lewis, A. J., Austin, D. W., Kulkarni, J., Dodd, S., de Castella, A., Fitzgerald, P. B. & Berk, M. (2017). Impact of irritability: a 2-year observational study of outpatients with bipolar I or schizoaffective disorder. BIPOLAR DISORDERS, 19 (3), pp.184-197. https://doi.org/10.1111/bdi.12486. Persistent Link: http://hdl.handle.net/11343/292837

Cited by

Sorted by citations

Authors
Berk, L., Hallam, K. T., Venugopal, K., Lewis, A. J., Austin, D. W., Kulkarni, J., Dodd, S., de Castella, A., Fitzgerald, P. B., & Berk, M.
Affiliations
  • Barwon Health (AU)
  • The University of Melbourne (AU)
  • SA Health (AU)
  • Murdoch University (AU)
  • Deakin University (AU)
  • The Alfred Hospital (AU)
  • Monash Alfred Psychiatry Research Centre (MAPrc) Monash University Central Clinical School and The Alfred Melbourne Vic. Australia
Corresponding author
Berk, Lesley
Venue
Bipolar Disorders
Publisher
Wiley
Published
2017-05
Volume
19
Issue
3
Pages
184-197
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W2611493211
Cited by
22
References
109
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 4 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 2
FWCI
2.25
Type
journal article
Language
en
Open access
Locations
  • Bipolar Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Murdoch University Research Portal (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Figshare (submittedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion)
Funders
  • National Health and Medical Research Council (1059660, 606907)
  • National Institutes of Health
  • Geelong Region Medical Research Foundation
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
Keywords
irritability, bipolar I disorder, schizoaffective disorder, disease severity, quality of life, suicidality, functional disability, social support, psychotic symptoms, mania, depression, symptom burden
MeSH terms
Activities of Daily Living, Adult, Australia, Bipolar Disorder, Female, Humans, Irritable Mood, Male, Middle Aged, Outpatients, Psychotic Disorders, Quality of Life, Severity of Illness Index, Social Support, Cohort Studies, Outcome Assessment, Health Care, Cost of Illness, Diagnostic and Statistical Manual of Mental Disorders, Suicidal Ideation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review